Ionis Pharmaceuticals | IONS - Current Assets


Ionis Pharmaceuticals reported $2.94B in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Agios Pharmaceuticals USD 834.84M 107.21M Mar/2026
Alnylam Pharmaceuticals USD 4.22B 168.65M Mar/2026
Arrowhead Research USD 1.84B 665.36M Mar/2026
Astellas Pharma JPY 1.42T 19.35B Mar/2026
BioCryst Pharmaceuticals USD 373.62M 30.72M Mar/2026
BioMarin Pharmaceutical USD 4.61B 651.58M Mar/2026
Celltrion KRW 481.57B 10.97B Mar/2026
Cspc Pharmaceutical CNY 22.25B 359.48M Dec/2025
Deva Holding AS TRY 9.13B 1.61B Sep/2023
Divis Laboratories Ltd INR 110.96B 12.53B Mar/2026
Exelixis USD 1.21B 234.65M Mar/2026
Halozyme Therapeutics USD 1B 177.83M Mar/2026
Ionis Pharmaceuticals USD 2.94B 52M Mar/2026
Kangmei Pharma CNY 6.8B 225.83M Mar/2026
Knight Therapeutics CAD 394.84M 5.86M Dec/2025
Laboratorios Farma EUR 509.33M 128.63M Dec/2023
Malin Corporation EUR 62.6M 26.7M Dec/2024
Medical Developments International AUD 33.75M 1.79M Dec/2025
Moderna USD 5.77B 774M Mar/2026
Nektar Therapeutics USD 266.27M 15.09M Dec/2025
Neuren Pharmaceuticals AUD 332.23M 11.98M Dec/2025
Neurocrine Biosciences USD 2.44B 86.6M Mar/2026
Novartis USD 26.61B 3.85B Mar/2026
Omeros USD 69.65M 26.53M Jun/2025
OPKO Health USD 535.36M 46.52M Mar/2026
Organigram Holdings CAD 250.09M 6.46M Mar/2026
Ovoca Bio EUR 1.56M 3.39M Jun/2025
Pfizer USD 42.82B 76M Mar/2026
Pharma Mar EUR 273.45M 9.96M Mar/2026
PTC Therapeutics USD 2.25B 19.94M Mar/2026
Qiagen NV USD 2B 535.87M Dec/2025
Regeneron Pharmaceuticals USD 18.21B 187.3M Mar/2026
Roche Holding CHF 38.73B 3.03B Dec/2025
Sarepta Therapeutics USD 2.31B 228.06M Mar/2026
Sartorius EUR 1.92B 157.2M Mar/2026
Sino Biopharmaceutical CNY 33.82B 9.13B Jun/2025
Tilray USD 729.32M 28.18M Sep/2025
Ultragenyx Pharmaceutical USD 657M 294M Mar/2026
Vertex Pharmaceuticals USD 11.73B 529.3M Mar/2026
Zealand Pharma A/S 15.67B 950.94M Dec/2025
Zz Pientze Pharmaceu CNY 11.43B 728.95M Mar/2026